2019
DOI: 10.18632/aging.102281
View full text | Cite
|
Sign up to set email alerts
|

Abstract: Glucuronic acid is a metabolite of glucose that is involved in the detoxification of xenobiotic compounds and the structure/remodeling of the extracellular matrix. We report for the first time that circulating glucuronic acid is a robust biomarker of mortality that is conserved across species. We find that glucuronic acid levels are significant predictors of all-cause mortality in three population-based cohorts from different countries with 4-20 years of follow-up (HR=1.44, p=2.9×10-6 in the discovery cohort; … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 91 publications
(74 reference statements)
0
18
0
Order By: Relevance
“…Multiple mechanisms may underlie the increased levels of glucuronic acid. One of the most reasonable possibilities involves the cleavage of glucuronic acid from glucuronidated xenobiotics by gut β-glucuronidase-bacteria [ 65 ]. Escherichia are among the opportunistic pathogens in the human gut that harbor a β-glucuronidase enzyme [ 66 , 67 ] and cause the release of glucuronic acid and, consequently, of xenobiotics, such as environmental toxins and drug metabolites with pro-inflammatory effects, that interfere with their inactivation and elimination via the GI tract [ 65 , 68 ].…”
Section: Discussionmentioning
confidence: 99%
“…Repeated measures of blood-based biomarkers in rodents may be limited due to the amount of blood required/available. Previous longitudinal studies in rodents have mainly focused on markers of longevity (Acuna-Castillo et al, 2006;Ho et al, 2019). Thus, a blood-based biomarker concerning cognitive function represents an important area for exploration in future longitudinal studies.…”
Section: Blood Biomarkersmentioning
confidence: 99%
“…DSEL (dermatan sulfate epimerase-like) is implicated in D-glucuronic acid metabolism and tumor rejection. A recent study has shown that glucuronic acid levels increase with age and predict future healthspan-related outcomes 40 . Furthermore, DSEL is highly expressed in the brain and has been found associated with AD in an imaging-wide association study 41 .…”
Section: Resultsmentioning
confidence: 99%
“…There is growing interest in predicting the risks for diseases and complex traits using polygenic risk scores (Khera et al, 2018). Previous studies have predicted longevity and life span based mainly on animal models (Huang et al, 2004; Shen et al, 2014; Swindell et al, 2008) or the use of single biomarker (Ho et al, 2019; Whittemore et al, 2019). One recent study using the UK Biobank dataset applied polygenic risk score for life span prediction with good performance but was limited by utilizing summary statistics for life span based on parental data (Timmers et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…For example, a recent genetic study reported that a polygenic score could identify people with the top 10% parental survival PRS, who might outlive an average of 5 years those with the bottom 10% parental survival PRS (Timmers et al, 2019). In addition, circulating glucuronic acid levels (Ho et al, 2019) or telomeres (Whittemore et al, 2019) have been used as biomarkers for life span prediction. To date, there are very few studies that explore the potential of life span prediction by using a combination of genetic data, disease conditions, and lifestyle factors.…”
Section: Introductionmentioning
confidence: 99%